A person with cataracts had a rare gene change that might make it harder for their cells to take in creatine, based on lab tests.
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
A person with cataracts had a rare gene change that might make it harder for their cells to take in creatine, based on lab tests.
See the technical phrasing
A genetic variant in the MCT12 gene (p.G407S), identified in a human patient with age-related cataract, is associated with significantly reduced creatine transport activity in experimental in vitro systems.
What the research says
Supports
1 study
Study: The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporter.
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies